USP Statement on Mifepristone Approval Oral Argument Before the Supreme Court
March 29, 2024
March 29, 2024
ROCKVILLE, Maryland, March 29 -- The U.S. Pharmacopeia, an organization that says it focuses on building trust in the supply of safe, quality medicines, issued the following agency statement on March 28, 2024:
* * *
The U.S. Supreme Court heard arguments this week related to the approval of mifepristone in Food and Drug Administration v. Alliance for Hippocratic Medicine and Danco Laboratories, LLC v. Alliance for Hippocratic Medicine. We are concerned that upholding th . . .
* * *
The U.S. Supreme Court heard arguments this week related to the approval of mifepristone in Food and Drug Administration v. Alliance for Hippocratic Medicine and Danco Laboratories, LLC v. Alliance for Hippocratic Medicine. We are concerned that upholding th . . .